According to All India Drug Action Network (AIDAN),despite the Government’s decision of price capping of 42 anti-cancer drugs most cancer medicines still remain unaffordable to most Indians because there is no curb on profiteering by pharma manufacturers.Profiteering means unfair profit realized by traders by manipulating prices,tax rate adjustment among others. They have said that the… Continue reading Most anti-cancer drugs costly despite price cap, says AIDAN
Tag: Drug Pricing
Govt brings 42 non-scheduled cancer drugs under price control
National Pharmaceutical Pricing Authority (NPPA) has invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control.This will cap trade margin at 30%, which would reduce their retail prices by up to 85%.The trade margin is the difference between the price at which the manufacturers sell to trade and… Continue reading Govt brings 42 non-scheduled cancer drugs under price control
Decision likely today to cap retailer margins of 73 drugs
A relief to patients will soon come up as the drug price regulator National Pharmaceutical Pricing Authority (NPPA) is expected to cap trade margins of 73 medicines for cancer and rare diseases.The trade margin is the difference between the price at which the manufacturers sell to trade and the price that patients pay(maximum retail price).… Continue reading Decision likely today to cap retailer margins of 73 drugs
Kerala sets up drug price monitor
Kerala has become the first state to set up a Price Monitoring and Research Unit (PMRU). It aims to track violation of prices of essential drugs and medical devices under the Drugs Price Control Order (DPCO) — the orders issued by Government declaring a ceiling price for essential and lifesaving medicines. The functions of PMRU… Continue reading Kerala sets up drug price monitor
